Diabetes and Glucose Metabolism

Diabetes

Be a Leader in Research and Practice

Explore all the ways we support research and practice - including the recently published Hypoglycemia Blueprint, Diabetes Technology Practice Guideline, and research on reducing cardiovascular disease in diabetes.

Type 1 Diabetes Linked to Gut Inflammation, Bacteria Changes
January 19, 2017 | People with Type 1 diabetes exhibit inflammation in the digestive tract and gut bacteria­—a pattern that differs from individuals who do not have diabetes or those who have celiac disease, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism

Endocrine Society Calls for Solutions Regarding Insulin Price Crisis
December 07, 2016 | The Endocrine Society lauds Novo Nordisk’s recent announcement that it would limit price increases for its therapies, including insulin, and hopes that other entities in the insulin supply chain…

I’m Still Here: Diabetes & The Aging Patient
December 2016 | As diabetes patients are living longer, endocrinologists are finding themselves faced with a unique set of treatment challenges not often found in younger patients. From cognitive function to…

Low Blood Glucose Levels in Hospitalized Patients Linked to Increased Mortality Risk
November 17, 2016 | In hospitalized patients, low blood sugar—also known as hypoglycemia—is associated with increased short- and long-term mortality risk, according to a new study published in the Endocrine Society’s…

Hypoglycemia: A Comprehensive Approach in the US
November 2016 | The Endocrine Society leads effort to reduce the incidence of hypoglycemia by developing a comprehensive blueprint with diabetes stakeholders recommending actions for how the community can affect…

Diabetes and Bones: An Underappreciated Complication
November 2016 | Diabetes can be weakening the skeleton despite apparently good bone mineral density scores. Fortunately, standard osteoporosis treatments appear to be just as successful in patients with diabetes…

Pancreas Donors: A Key to a Diabetes Cure?
November 2016 | If you haven’t heard of the JDRF Network for the Pancreatic Organ Donors with Diabetes aka nPOD, you will. nPOD is not just a research lab or a clearing house for pancreas tissue from donors with…

Experts Recommend Continuous Glucose Monitors for Adults with Type 1 Diabetes
September 26, 2016 | Endocrine Society publishes Clinical Practice Guideline evaluating technologies for treating diabetes. The Endocrine Society today issued a Clinical Practice Guideline recommending continuous glucose monitors…

The Bionic Pancreas Is Getting Closer to Reality | TIME magazine
April 1, 2016 | The invention could seriously change the management of type-1 diabetes. The race is on for what may be the biggest innovation in decades for Type 1 diabetes management—the bionic pancreas—and on…

Updates in Cardiovascular Risk Reduction in Type 2 Diabetes: New Insights and Outcomes in Treatment Options
ENDO Satellite Symposium | 2.5 AMA PRA Category 1 Credits™ and ABIM MOC Part 2 points
Chair: Bernard Zinman, MD
Faculty: Naveed Sattar, PhD, FRCP; Hertzel C Gerstein, MD; and Silvio E Inzucchi, MD
Identify cardiovascular risk factors and develop strategies to reduce risks in patients with diabetes using new insights and outcomes data.

The Effective Use of Insulin in Type 2 Diabetes: A Focus on Treatment Advances
ENDO Satellite Symposium | 2.5 AMA PRA Category 1 Credits™
Chair: John (Jack) L. Leahy, MD
Faculty: Lawrence Blonde, MD; Marie E. McDonnell, MD; and Janet B. McGill, MD
How well do you know about the latest insulin options? Keep up to date on advances and algorithms.

New Options and Combinations in Diabetes Management: Optimizing Control and Individualizing Treatment
ENDO Satellite Symposium | 2.0 AMA PRA Category 1 Credits™
Chair: Anne L. Peters, MD
Faculty: Carol H. Wysham, MD; David M. Kayne, MD; and Janet B. McGill, MD
Use new options in GLP-1 receptor agonists, basal insulins, and combinations therein to improve patient outcomes.

Epigenetic Changes in Patients with Type 2 Diabetes and Impact on Insulin Secretion and Action
ENDO Session | No credit available
Charlotte Ling, PhD
Learn about recent discoveries in potential epigenetic contributions to the development and progression of type 2 diabetes.

Transitions of Care: Type 1 Diabetes
Practice Resource | No credit available
Find resources for you and your patients to facilitate the challenging transition from pediatric to adult endocrine practice.

Endocrine Fellows Series: Type 1 Diabetes Care and Management 2016
Fellows Workshop Webcast | 15.0 AMA PRA Category 1 Credits™
Program Directors: Irl B. Hirsch, MD and Linda Siminerio, PhD
Engage in a comprehensive program for pediatric and adult endocrine fellows including foundation education, practice management strategies, and practical approaches to challenging cases.

Diabetes Diagnosis & Management 2016
Workshop Webcast | 8.25 AMA PRA Category 1 Credits™ and ABIM MOC Part 2 points
Planning Chairs: Johns (Jack) L. Leahy, MD; Jane E. B. Reusch, MD; and Carol H. Wysham, MD
Expert faculty provide state-of-the-art updates on cardiometabolic co-morbidities, new treatment options, and day-to-day strategies to manage patients with diabetes.

Endocrine Facts & Figures: Diabetes
Research Resource | No credit available
Advisory Panel Chair: Robert A. Vigersky, MD
Updated epidemiological data and in-depth discussion on the common types of diabetes and related conditions with current citations and expert insights.

Autoimmune Diseases in Children and Adults with Type 1 Diabetes from the T1D Exchange Clinic Registry
JCEM | September 27, 2016
Jing W. Hughes, Tonya D. Riddlesworth, Linda A. DiMeglio, Kellee M. Miller, Michael R. Rickels and Janet B. McGill
Type 1 diabetes (T1D) is associated with other autoimmune diseases (AIDs), but the prevalence and associated predictive factors for these comorbidities of T1D across all age groups have not been…

Spontaneous Hypoglycemia after Islet Transplantation: The Case for Using Non-Hepatic Sites
JCEM | September 9, 2016
R. Paul Robertson
This Perspective provides a brief history of intrahepatic alloislet and autoislet transplantation in humans and an update of the recent success rates. It also examines the important role that…

Mechanisms Underlying the Pathogenesis of Isolated Impaired Glucose Tolerance in Humans
JCEM | September 7, 2016
Ron T. Varghese, Chiara Dalla Man, Anu Sharma, Ivan Viegas, Cristina Barosa, Catia Marques, Meera Shah, John M. Miles, Robert A. Rizza, John G. Jones, Claudio Cobelli and Adrian Vella
Prediabetes is a heterogeneous disorder classified on the basis of fasting glucose concentrations and 2-hour glucose tolerance. We sought to determine the relative contributions of insulin secretion…

Dapagliflozin as Additional Treatment to Liraglutide and Insulin in Patients with Type 1 Diabetes
JCEM | August 4, 2016
Nitesh D. Kuhadiya, Husam Ghanim, Aditya Mehta, Manisha Garg, Salman Khan, Jeanne Hejna, Barrett Torre, Antoine Makdissi, Ajay Chaudhuri, Manav Batra and Paresh Dandona
It is imperative that novel approaches to treatment of type 1 diabetes (T1D) are devised. The objective of the study was to investigate whether addition of dapagliflozin to insulin and liraglutide…

Increasing Insulin Availability Does Not Augment Postprandial Muscle Protein Synthesis Rates in Healthy Young and Older Men
JCEM | July 19, 2016
Bart B. L. Groen, Astrid M. H. Horstman, Henrike M. Hamer, Michiel de Haan, Janneau van Kranenburg, Jörgen Bierau, Martijn Poeze, Will K. W. H. Wodzig, Blake B. Rasmussen, and Luc J. C. van Loon
Skeletal muscle protein synthesis is highly responsive to food intake. It has been suggested that the postprandial increase in circulating insulin modulates the muscle protein synthetic response to…

A Novel and Practical Screening Tool for the Detection of Silent Myocardial Infarction in Patients with Type 2 Diabetes
JCEM | June 14, 2016
Peter P. Swoboda, Adam K. McDiarmid, Bara Erhayiem, Philip Haaf, Ananth Kidambi, Graham J. Fent, Laura E. Dobson, Tarique A. Musa, Pankaj Garg, Graham R. Law, Mark T. Kearney, Julian H. Barth, Ramzi Ajjan, John P. Greenwood and Sven Plein
Silent myocardial infarction (MI) is a prevalent finding in patients with type 2 diabetes and is associated with significant mortality and morbidity. Late gadolinium enhancement (LGE) by cardiovascular…

Affordable Care Act Implementation: Challenges and Opportunities to Impact Patients with Diabetes
JCEM | April 04, 2016
Alvin C. Powers, Jason A. Wexler, Robert W. Lash, Meredith C. Dyer, Mila N. Becker, and Robert A. Vigersky
In the United States, slightly more than half of all adults with diabetes receive guideline-consistent care. A smaller proportion has adequate cardiovascular risk factor control. Current care…

Evaluation of Bone Mineral Density and Bone Biomarkers in Patients with Type 2 Diabetes Treated with Canagliflozin
JCEM | November 18, 2015
John P. Bilezikian, Nelson B. Watts, Keith Usiskin, David Polidori, Albert Fung, Daniel Sullivan and Norm Rosenthal
Canagliflozin is a sodium glucose cotransporter 2 inhibitor developed to treat type 2 diabetes mellitus (T2DM). Our objective is to describe the effects of canagliflozin on bone mineral density…

Diabetes Technology—Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults
JCEM | September 2, 2016
Anne L. Peters(chair), Andrew J. Ahmann, Tadej Battelino, Alison Evert, Irl B. Hirsch, M. Hassan Murad, William E. Winter, and Howard Wolpert
Continuous subcutaneous insulin infusion and continuous glucose monitoring have an important role in the treatment of diabetes. Data from randomized controlled trials are limited on the use of…

Diabetes and Pregnancy
JCEM | December 4, 2013
Ian Blumer, Eran Hadar, David R. Hadden, Lois Jovanovič, Jorge H. Mestman, M. Hassan Murad, and Yariv Yogev
Using an evidence-based approach, this Diabetes and Pregnancy Clinical Practice Guideline addresses important clinical issues in the contemporary management of women with type 1 or type 2 diabetes…

Management of Hyperglycemia in Hospitalized Patients in Non-critical Care Setting
JCEM | July 2, 2013
Guillermo E. Umpierrez, Richard Hellman, Mary T. Korytkowski, Mikhail Kosiborod, Gregory A. Maynard, Victor M. Montori, Jane J. Seley, and Greet Van den Berghe
Hyperglycemia is a common, serious, and costly health care problem in hospitalized patients. Observational and randomized controlled studies indicate that improvement in glycemic control results…

Evaluation and Management of Adult Hypoglycemic Disorders
JCEM | April 30, 2011
Philip E. Cryer, Lloyd Axelrod, Ashley B. Grossman, Simon R. Heller, Victor M. Montori, Elizabeth R. Seaquist, and F. John Service
We recommend evaluation and management of hypoglycemia only in patients in whom Whipple's triad--symptoms, signs, or both consistent with hypoglycemia, a low plasma glucose concentration, and…

Primary Prevention of Cardiovascular Disease and Type 2 Diabetes in Patients at Metabolic Risk
JCEM | January 14, 2009
James L. Rosenzweig, Ele Ferrannini, Scott M. Grundy, Steven M. Haffner, Robert J. Heine, Edward S. Horton, and Ryuzo Kawamori
Healthcare providers should incorporate into their practice concrete measures to reduce the risk of developing CVD and T2DM. These include the regular screening and identification of patients at…

53rd Annual Clinical Diabetes and Endocrinology
Dates: January 21 - 24, 2017
Location: Aspen/Snowmass, Colorado, Unites States
Sponsor: National Jewish Health in collaboration with The Clinical Diabetes Endocrine Institute

Keystone Symposium on Diabetes
Dates: January 22 - 26, 2017
Location: Keystone, Colorado, United States
Sponsor: Keystone Symposia on Molecular and Cellular Biology

Metabolic Syndrome Bench to Clinic
Dates: March 11, 2017
Location: Baltimore, Maryland, United States
Sponsor: Society of Toxicology

2017 Gordon Research Conference on IGF and Insulin System in Physiology and Disease
Dates: March 12 - 17, 2017
Location: Ventura, California, United States
Sponsor: Gordon Research Conferences

Sex and Gender Factors Affecting Metabolic Homeostasis and Diabetes and Obesity
Dates: March 19 - 23, 2017
Location: Tahoe City, California, United States
Sponsor: Keystone Symposia on Molecular and Cellular Biology

ENDO 2017 Preconference
2017 Rachmiel Levine Arthur Riggs Diabetes Research Symposium

Dates: March 28 - 31, 2017
Location: Orlando, Florida, United States
Sponsor: City of Hope

ENDO 2017 Preconference
Endocrine Fellows Series: Type 1 Diabetes Care and Management

Dates: March 29 - 30, 2017
Location: Orlando, Florida, United States
Sponsor: Endocrine Society

ENDO 2017 Preconference
Diabetes Diagnosis & Management 2017

Dates: March 31, 2017
Location: Orlando, Florida, United States
Sponsor: Endocrine Society

Popular Resources